Article Information
History
- May 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Dr Jamie Lopez Bernal1,2,3,*, (Consultant Medical Epidemiologist),
- Prof Nick Andrews1,2, (Senior Statistician),
- Dr Charlotte Gower1, (Senior Epidemiologist),
- Dr Julia Stowe1, (Senior Epidemiologist),
- Elise Tessier1, (Senior Epidemiologist),
- Dr Ruth Simmons1, (Senior Epidemiologist) and
- Prof Mary Ramsay1,2, (Head of Immunisations)
- 1Public Health England, London, United Kingdom
- 2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
- 3NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, United Kingdom
- ↵*Corresponding author: jamie.lopezbernal2{at}phe.gov.uk; 61 Colindale Ave, London, NW9 5EQ, UK;
Posted May 18, 2021.
Effectiveness of BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on mortality following COVID-19
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
Author Videos